000909624 001__ 909624
000909624 005__ 20230123110648.0
000909624 0247_ $$2doi$$a10.1007/s00259-022-05817-6
000909624 0247_ $$2ISSN$$a0340-6997
000909624 0247_ $$2ISSN$$a1432-105X
000909624 0247_ $$2ISSN$$a1619-7070
000909624 0247_ $$2ISSN$$a1619-7089
000909624 0247_ $$2Handle$$a2128/33062
000909624 0247_ $$2pmid$$a35536420
000909624 0247_ $$2WOS$$aWOS:000793100100001
000909624 037__ $$aFZJ-2022-03295
000909624 082__ $$a610
000909624 1001_ $$0P:(DE-HGF)0$$aPiccardo, Arnoldo$$b0
000909624 245__ $$aJoint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
000909624 260__ $$aHeidelberg [u.a.]$$bSpringer-Verl.$$c2022
000909624 3367_ $$2DRIVER$$aarticle
000909624 3367_ $$2DataCite$$aOutput Types/Journal article
000909624 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1670915112_2542
000909624 3367_ $$2BibTeX$$aARTICLE
000909624 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000909624 3367_ $$00$$2EndNote$$aJournal Article
000909624 520__ $$aPositron emission tomography (PET) has been widely used in paediatric oncology. 2-Deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) is the most commonly used radiopharmaceutical for PET imaging. For oncological brain imaging, different amino acid PET radiopharmaceuticals have been introduced in the last years. The purpose of this document is to provide imaging specialists and clinicians guidelines for indication, acquisition, and interpretation of [18F]FDG and radiolabelled amino acid PET in paediatric patients affected by brain gliomas. There is no high level of evidence for all recommendations suggested in this paper. These recommendations represent instead the consensus opinion of experienced leaders in the field. Further studies are needed to reach evidence-based recommendations for the applications of [18F]FDG and radiolabelled amino acid PET in paediatric neuro-oncology. These recommendations are not intended to be a substitute for national and international legal or regulatory provisions and should be considered in the context of good practice in nuclear medicine. The present guidelines/standards were developed collaboratively by the EANM and SNMMI with the European Society for Paediatric Oncology (SIOPE) Brain Tumour Group and the Response Assessment in Paediatric Neuro-Oncology (RAPNO) working group. They summarize also the views of the Neuroimaging and Oncology and Theranostics Committees of the EANM and reflect recommendations for which the EANM and other societies cannot be held responsible.Keywords: DOPA; FDG; FET; Gliomas; MET; PET-CT; Paediatric PET; Paediatric brain imaging; Paediatric oncology.
000909624 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000909624 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000909624 7001_ $$0P:(DE-HGF)0$$aAlbert, Nathalie L.$$b1
000909624 7001_ $$0P:(DE-HGF)0$$aBorgwardt, Lise$$b2
000909624 7001_ $$0P:(DE-HGF)0$$aFahey, Frederic H.$$b3
000909624 7001_ $$0P:(DE-HGF)0$$aHargrave, Darren$$b4
000909624 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b5
000909624 7001_ $$0P:(DE-HGF)0$$aJehanno, Nina$$b6
000909624 7001_ $$00000-0002-3396-4880$$aKurch, Lars$$b7$$eCorresponding author
000909624 7001_ $$0P:(DE-HGF)0$$aLaw, Ian$$b8
000909624 7001_ $$0P:(DE-HGF)0$$aLim, Ruth$$b9
000909624 7001_ $$0P:(DE-HGF)0$$aLopci, Egesta$$b10
000909624 7001_ $$0P:(DE-HGF)0$$aMarner, Lisbeth$$b11
000909624 7001_ $$0P:(DE-HGF)0$$aMorana, Giovanni$$b12
000909624 7001_ $$0P:(DE-HGF)0$$aYoung Poussaint, Tina$$b13
000909624 7001_ $$0P:(DE-HGF)0$$aSeghers, Victor J.$$b14
000909624 7001_ $$0P:(DE-HGF)0$$aShulkin, Barry L.$$b15
000909624 7001_ $$0P:(DE-HGF)0$$aWarren, Katherine E.$$b16
000909624 7001_ $$0P:(DE-HGF)0$$aTraub-Weidinger, Tatjana$$b17
000909624 7001_ $$0P:(DE-HGF)0$$aZucchetta, Pietro$$b18
000909624 773__ $$0PERI:(DE-600)2098375-X$$a10.1007/s00259-022-05817-6$$gVol. 49, no. 11, p. 3852 - 3869$$n11$$p3852 - 3869$$tEuropean journal of nuclear medicine and molecular imaging$$v49$$x0340-6997$$y2022
000909624 8564_ $$uhttps://juser.fz-juelich.de/record/909624/files/PDF.pdf$$yOpenAccess
000909624 909CO $$ooai:juser.fz-juelich.de:909624$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000909624 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b5$$kFZJ
000909624 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000909624 9141_ $$y2022
000909624 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-02
000909624 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000909624 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-02-02$$wger
000909624 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000909624 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-02
000909624 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J NUCL MED MOL I : 2021$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-23
000909624 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bEUR J NUCL MED MOL I : 2021$$d2022-11-23
000909624 920__ $$lyes
000909624 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000909624 980__ $$ajournal
000909624 980__ $$aVDB
000909624 980__ $$aUNRESTRICTED
000909624 980__ $$aI:(DE-Juel1)INM-3-20090406
000909624 9801_ $$aFullTexts